Advertisement

A simple Haematology As new research discovered, this will help people identify people in the early stages of Parkinson’s disease.

This study was published on Friday Revista ‘Nature Aging’Last is the last to identify Parkinson’s initial warning signals, A neurodegenerative disease that affects about 10 million people It occurs when the brain stops slowly producing chemical dopamine in areas that control movement and balance.

Parkinson has no treatmentIt causes tremors, stiffness, slow movements and cognitive impairment. Most people are diagnosed on the basis of these symptoms, but within that, more than 60% of the dopaminergic neurons have already been degraded, which is why scientists are looking for ways to detect patients before.

For the new study, Israeli researchers Compares blood and brain tissue data Between Parkinson’s patients and those who enjoy good health. They focused on small RNA molecules called transformer RNA pieces (FRT), which plays a role in neurological problems like Parkinson.

Two main biomarks arose; One is associated with Parkinson and the other Progress. The findings say that The use of blood analysis To measure the distance between them, it may act as an additional early diagnosis of the disease.

“By focusing on FRT, we have opened a new window Molecular changes that occur in stages Early illness, “One of the authors of the University of Jerusalem and a professor of molecular neurologist, said Hermana Sorek.

Need additional studies to ensure results

But researchers have said that in time to confirm their results, Parkinson Parkinson requires great studies to follow the most different group of patients Understand how changes in these biomarks They affect the results of patients.

If blood analysis is not clear Can distinguish between Parkinson And other conditions Similar initial signs. “Understanding how much work is needed to continue to test and verify these potential evidence, especially how to distinguish other signs such as Parkinson,” said Parkinson’s UK research director Eurneus Health ‘David Dexter.

“This research refers to A new angle to explore in search From the biological marker for Parkinson, “Textter added, which did not participate in the study. Other scientists have discovered other biomarks.

A study of funded by the EU And released last year He identified eight blood proteins to help Parkinson’s patients identify up to seven years for the appearance of major symptoms.

For the expectation Fast and reliable blood analysis for Parkinson Israeli researchers said “eliminate the uncertainty burden of affected persons, which can help doctors in the maintenance of these patients in the early stages of the disease and create new treatments.”

.

Story Credit

LEAVE A REPLY

Please enter your comment!
Please enter your name here